The Pluripotency Factor Musashi-2 Is a Novel Target for Lung Cancer Therapy

Annals of the American Thoracic Society - United States
doi 10.1513/annalsats.201707-608mg
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Thoracic Society

Related search

P084 Musashi-2 Expression Is an Prognostic Factor for Postoperative Survival in Patients With Non-Small Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

DDX49 Is a Novel Biomarker and Therapeutic Target for Lung Cancer Metastases

Journal of Cellular and Molecular Medicine
Molecular MedicineCell Biology
2020English

BH4 Domain of BCL-2 as a Novel Target for Cancer Therapy

Drug Discovery Today
Drug DiscoveryPharmacology
2016English

Advances in Target Therapy for Lung Cancer

Japanese Journal of Clinical Oncology
Nuclear MedicineRadiologyCancer ResearchOncologyImagingMedicine
2009English

Insulin-Like Growth Factor-Binding Protein-2 Is a Target for the Immunomodulation of Breast Cancer

Cancer Research
Cancer ResearchOncology
2008English

Advances in Target Therapy in Lung Cancer

European Respiratory Review
PulmonaryRespiratory Medicine
2015English

Molecular Imaging of N-Linked Glycosylation Suggests Glycan Biosynthesis Is a Novel Target for Cancer Therapy

Clinical Cancer Research
Cancer ResearchOncology
2010English

2394 Sodium-Glucose Transporter 2 Is a Novel Diagnostic and Therapeutic Target for Early-Stage Lung Adenocarcinoma

Journal of Clinical and Translational Science
Medicine
2018English

Pancreatic Cancer Stem Cells: Emerging Target for Designing Novel Therapy

Cancer Letters
Cancer ResearchOncology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy